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Using the Virtual Heart Model to Validate the Mode-Switch Pacemaker Operation
Abstract
Artificial pacemakers are one of the most widely-used implantable devices today, with millions implanted
worldwide. The main purpose of an artificial pacemaker is to treat bradycardia, or slow heart beats, by
pacing the atrium and ventricles at a faster rate. While the basic functionality of the device is fairly simple,
there are many documented cases of death and injury due to device malfunctions. The frequency of
malfunctions due to firmware problems will only increase as the pacemaker operations become more
complex in an attempt to expand the use of the device. One reason these malfunctions arise is that there
is currently no methodology for formal validation and verification of medical device software, as there are
in the safety-critical domains of avionics and industrial control automation. We have developed a timedautomata based Virtual Heart Model (VHM) to act as platform for medical device software validation and
verification. Through a case study involving multiple arrhythmias, this investigation shows how the VHM
can be used with closed-loop operation of a pacemaker to validate the necessity and functionality of the
complex mode-switch pacemaker operation. We demonstrate the correct pacemaker operation, to switch
from one rhythm management mode to another, in patients with supraventricular tachycardias.

Keywords
implantable medical devices, cardiac pacemakers, heart model, formal methods, timed automata

Disciplines
Biomedical Engineering and Bioengineering | Electrical and Computer Engineering

Comments
Jiang, Z., Connolly, A., & Mangharam, R. (2010). Using the virtual heart model to validate the mode-switch
pacemaker operation. 32nd Intl. Conf. IEEE Engineering in Medicine and Biology Society, 6690-3. doi:
10.1109/IEMBS.2010.5626262
© 2010 IEEE. Personal use of this material is permitted. Permission from IEEE must be obtained for all
other uses, in any current or future media, including reprinting/republishing this material for advertising or
promotional purposes, creating new collective works, for resale or redistribution to servers or lists, or
reuse of any copyrighted component of this work in other works.

This conference paper is available at ScholarlyCommons: https://repository.upenn.edu/mlab_papers/64

Using the Virtual Heart Model to Validate the Mode-Switch Pacemaker Operation
Zhihao Jiang, Allison Connolly and Rahul Mangharam
Department of Electrical and System Engineering
University of Pennsylvania
{zhihaoj, allison and rahulm}@seas.upenn.edu
Abstract—Artificial pacemakers are one of the most widely-used
implantable devices today, with millions implanted worldwide. The
main purpose of an artificial pacemaker is to treat bradycardia,
or slow heart beats, by pacing the atrium and ventricles at a
faster rate. While the basic functionality of the device is fairly
simple, there are many documented cases of death and injury
due to device malfunctions. The frequency of malfunctions due to
firmware problems will only increase as the pacemaker operations
become more complex in an attempt to expand the use of the
device. One reason these malfunctions arise is that there is
currently no methodology for formal validation and verification
of medical device software, as there are in the safety-critical
domains of avionics and industrial control automation. We have
developed a timed-automata based Virtual Heart Model (VHM)
to act as platform for medical device software validation and
verification. Through a case study involving multiple arrhythmias,
this investigation shows how the VHM can be used with closed-loop
operation of a pacemaker to validate the necessity and functionality
of the complex mode-switch pacemaker operation. We demonstrate
the correct pacemaker operation, to switch from one rhythm
management mode to another, in patients with supraventricular
tachycardias. 1

I. I NTRODUCTION
Between 1990 and 2002, over 8,000 pacemakers were surgically explanted due to device malfunctions, and since 2002
over 200,000 pacemakers and implantable cardiac defibrillators
(ICDs) were recalled[1]. While most recalls did not require
device explantation, they still posed significant risk to the patient
because of malfunctioning software. The software could be
reprogrammed by a physician in the office, but this required
physician time and resources which may prevent the correction
of errors in all implanted pacemakers and put patients’ lives at
risk[2]. The use of a model as the platform for software testing,
validation and verification has been shown to be useful because
it provides a unifying point of reference for all brands of medical
devices and a mathematical basis for software correctness. A
spatio-temporal heart and device-in-loop model can provide
a large variety of clinically relevant test cases, beyond the
capability of synthetically generated signals[3]. The task of
creating a realistic platform for the validation and verification of
medical device software is complicated because the underlying
physiology is not fully understood. Any model of the heart must
be restricted to specific cases that are validated as clinically
relevant. Thus, the major challenge is not in validating the
medical device software, but in first validating the heart model
itself for a sufficiently large number of cases.
1 This research work was supported in part by the NSF CPS-0931239, CSR0834517 and MRI-0923518 grants.

A.. Virtual Heart Model Platform
A virtual heart model (VHM) has been developed as a
basic platform for validation and verification of implantable
medical device software. The timing properties of the heart’s
electrical conduction system are extracted to create a timedautomata model. The refractoriness of tissues are modeled as
node automata. Each node contains three states, the effective
refractory period or blocking interval, the relative refractory
period where preexcitation can occur, and the rest period.
The conduction properties between nodes are modeled as path
automata. Each path contains timers to model the antegrade and
retrograde conduction of activation signals along that path.
A functional interface models probes to output electrograms,
which can be used in closed-loop interactions with medical
devices. Each probe monitors the antegrade and retrograde
timers of neighboring paths and produces a spike according
to the relative distance from these activations to the probe.
The VHM also provides a formal interface for interaction with
medical device software and for use in formal verification. Fig.
1 shows the principal conduction pathways within the heart
modeled by a 30+ node and path automata model. The heart
model is capable of generating clinically-relevant electrogram
signals from the standard probing points across the heart wall.
In addition, there is an interface for external pacing for electrophysiological testing. The synthetic electrograms for several
case studies have been validated by a electrophysiologist. The
same model also executes on a programmable hardware (FPGA)
platform for software-based and hardware-based device-in-loop
evaluation. For further details, refer to earlier work in [4].

Figure 1.
Virtual Heart Model Simulink environment. The network of
nodes and paths models the electrical conduction system the heart. Synthetic
electrograms are generated from the VHM and the bottom panel controls
programmed pacing.

B.. Organization of the Paper
We will use the VHM to investigate the different pacemaker
operating modes during the onset and termination of complex
cardiac arrhythmias involving the whole heart. Such spatiotemporal analysis requires a richer heart model to be used for
closed-loop functional and formal validation of the pacemaker
software prior to clinical trials. This paper focuses on the
mode-switch pacemaker operation, which occurs when the heart
switches from a tachycardic to a bradycardic arrhythmia, or vice
versa. The mode-switch becomes necessary when the pacemaker
delivers inappropriate therapy. Inappropriate therapy is characterized by an excessively fast ventricular rate as well as by atrioventricular asynchrony. The mode-switch operaton is validated
by proving that all therapies delivered by the pacemaker are
appropriate, meaning they maintain a proper ventricular rate and
provide atrio-ventricular synchrony.
II.M ODELING A PACEMAKER
A.. Basic Pacemaker Modes
In conjunction with the VHM, a model of an artificial
pacemaker has been developed to investigate the closed-loop
interaction between the physical system (heart) and the device
(pacemaker) for correctness of operation across a range of
cardiac arrhythmias. Pacemakers operate in different modes and
these are labelled using a three character system (e.g. xyz).
The first position describes the pacing locations, the second
location describes the sensing locations, and the third position
describes how the pacemaker software responds to sensing. For
example, VDI mode paces only the ventricle (V) while it senses
dually from both the atria and the ventricle (D) and the sensing
in the ventricle inhibits pacing in the ventricle (I). The DDD
mode paces both the atrium and ventricle (D), senses both (D),
and sensing can both activate or inhibit further pacing (D).
Pacemakers can have pace/sense leads in a single chamber or in
two chambers (atrium and ventricle). These modes are referred
to as low-level operations, as they perform the basic therapies
necessary to maintain a baseline heart beat. They form a basis
upon which more complicated therapeutic algorithms can be
implemented.
The previously developed model[4] contained only the five
basic timer components of a pacemaker to coordinate the
sensing and pacing of the device software. The main timer
component is the lower rate interval (LRI) which determines
the slowest heart beat allowed by the pacemaker. With these five
timer components, any mode of pacemaker from VVI (sensing
and pacing in the ventricles only) to DDD can be modeled.
Complex functionalities that exist in commercial pacemakers
were not included in the previous model.
B.. High-level Pacemaker Operations
Commercial pacemakers and other cardiac devices use counters, morphology detectors, and other attributes to detect arrhythmias before applying specialized pacing therapy[5]. For
example, a dual chamber pacemaker can detect atrial tachycardias by counting the number of atrial beats with rate above a programmed threshold[6]. Once an arrhythmia has been detected,
a high-level operation delivers specified therapy in order to deal

with and in some cases terminate the arrhythmia. Examples
of these high-level operations include atrial flutter response,
rate hysteresis and rate smoothing to gradually quicken or slow
pacing rates, and sudden bradycardia response.
III. M ODELING A RRHYTHMIAS IN THE VHM
While simple pacemaker operations can be satisfactorily
verified using pre-recorded electrogram signals, the high-level
operations require a complex and interactive platform for validation and verification. The VHM provides this interactive
device-in-the-loop environment, where pacing therapy from the
pacemaker software will directly cause changes in the VHM,
creating a more realistic testing environment. This also allows
the testing parameters to cover a greater span of arrhythmias.
With the VHM, we can create multiple arrhythmias to test the
interactions between different features of the pacemaker.
Cavotricuspid-Isthmus-Dependent (CTI) Atrial Flutter
(AFL) is a commonly seen supraventricular arrhythmia. The
physiology of the right atrium, shown in the right panel of Fig. 2,
lends itself to forming conduction pathways along pathological
tracks. Slow conduction through the CTI, the area bounded by
the inferior vena cava and the tricuspid valve annulus, creates
a long cycle length in the tissue and allows for the reentry
circuit to form[7]. Typical AFL occurs in the counter-clockwise
direction, with activation following the posterior atrial wall
through the CTI, along the inter-atrial septum, back across the
anterior wall, and down the exterior wall. Clockwise direction
conduction, known as reverse AFL, is also seen but is not as
common. AFL encompasses a large portion of the atrium in
a reentry circuit with rates up to 350 beats per minute. It is
associated with significantly high morbidity rates because it
occurs in transition from a regular rhythm to atrial fibrillation[8].
A dual chamber pacemaker is normally prescribed for patients
with chronic bradycardia, or slow heart rate. These patients can
have additional arrhythmias, including atrial flutter. The AFL
rate of 240 to 350 bpm dominates the intrinsic slow rate of the
SA node, and causes activation to conduct to both atria. Com-

Figure 2. (a) The straight arrow shows the view of the AFL circuit from
the right ventricle through the tricuspid valve into the right atrium, while the
curved area shows the direction of conduction. (b) The circuit is bounded by the
eustachian ridge (ER), connecting the inferior vena cava (IVC) and the coronary
sinus (CS), as well as the crista terminalis (CT), connecting the superior vena
cava (SVC) and the IVC. The wavy line shows slow conduction through the
CTI, bounded by the ER and the tricuspid valve (Adapted from [7]). (c) The AFL
circuit in the VHM extrapolates nodes and paths from the true physiology. The
numbers show the values of conduction timers in the paths, with corresponding
slow conduction path on the bottom.

Figure 3. The VHM has intermittent AFL with nearly 2:1 conduction. The AFL
terminates at 4000 ms and reveals the underlying bradycardia with extended
beat-to-beat intervals and slow rate.

monly, this rapid activation in the atria causes the conduction
properties of the tissue downstream towards the ventricles to
slow[9]. This blocks several activations from conducting to the
ventricles and results in a 2:1 atrium to ventricle conduction
ratio (shown in Fig. 3). The atrial rate is very fast while the
ventricular rate remains relatively normal, around 100 beats per
minute. When the AFL terminates on its own, the diseased heart
returns to a bradycardia state.
The reentry circuit for AFL is modeled in the VHM by
placing additional nodes and paths in the right atrium connected
to the SA node. In order to model the reentry circuit with
cycle length 226 msec, the sum of conduction timers for all
paths along the circuit equals the cycle length. The effective
refractory timers for the nodes in the circuit were set to 150
msec, which allows the condution to continue through the nodes
without encountering block. However, the effective refractory
timer for the AV node is known to be 500 msec. This means
that every other activation signal conducted through the atria
will be blocked at the AV node and not conduct to the nodes and
paths in the ventricles, causing 2:1 conduction. The underlying
bradycardia is modeled by setting the rest timer of the SA node
to be 1000 msec.
IV. PACEMAKER M ODE S WITCH O PERATION
AFL is significant not only because of its high rate of
occurrence, but also because it presents a complex situation that
requires complex pacemaker rhythm therapy. AFL on its own
is not life-threatening, because the tachycardia happens only
in the atria. The delay and block properties of the AV node
can maintain relatively normal ventricle rates. However, when
supraventricular tachycardias such as AFL occur in patients with
an artificial pacemaker, complications can arise if the pacemaker
follows the timing sequence for simple bradycardia. In DDD
mode, the pacemaker will pace the ventricles for every sensed
atrial event, which induces a ventricular tachycardia and compromises proper pumping function. The mode-switch operation
needs to be introduced so that the pacemaker can switch from
DDD mode to VDI mode during supraventricular tachycardia.
This prevents over-pacing the ventricles by decoupling the atrial
and ventricular sensing. The VDI pacemaker paces the ventricles
at the programmed LRI, not once for every sensed atrial event.
In order to validate the necessity and functionality of the
mode-switch operation, we implemented the mode switch pacemaker model in closed-loop simulation with the VHM with
bradycardia and transient AFL. The following section illustrates
how the DDD mode pacemaker produces undesired over-pacing
and induces a ventricular tachycardia, while the pacemaker with
mode-switch operation ensures appropriate therapy.

Figure 4. VVI Mode: The top two panels show the atrial and ventricular
electrograms sensed by the pacemaker. The bottom panel shows the labelled
pacemaker operation, with ventricular sensed (VS) and paced (VP) events. The
ventricles are paced at appropriate rates in both AFL and bradycardia, but
optimal function is not maintained as the atrium and ventricles are out of sync.

A.. AFL with VVI pacemaker
A single chamber pacemaker, ventricle only, can better treat
a heart with supraventricular arrhythmia than a DDD mode
pacemaker. Because the atria are beating very fast on their
own, atrial sensing is not necessary. The VVI pacemaker will
keep the ventricles contracting at the desired LRI rate. While
this is not optimal for pumping efficiency, it is sufficient, as
the ventricles are the chambers that drive blood throughout the
whole body. No pacemaker mode can slow down the atrial rate,
so focusing on maintaining the ventricular rate is the best that
can be done. Fig. 4 shows the VHM operating with a VVI
mode pacemaker. While the atrial electrogram shows very fast
excitation, the ventricular electrogram shows how the pacemaker
maintains a steady interval of 800ms, or 75 beats per minute, in
the ventricles during AFL. This rate is also maintained during
bradycardia, but the atria and ventricles are decoupled and
contract asynchronously, which produces inefficient pumping.
B.. AFL with DDD pacemaker
In many cases, patients require a dual chamber pacemaker
to maintain synchrony between atria and ventricles, such as
in bradycardia with heart block. The Post Ventricular Atrial
Refractory Period (PVARP) is a period after each ventricle event
that no atrial event should happen. In DDD mode pacemaker,
atrial events sensed during PVARP will be marked as AR
and will not trigger ventricular pacing[4]. Fig. 5 illustrates the
situation where a DDD pacemaker can cause more harm than
good. Although some atrial events fall into the PVARP period of
the pacemaker and are ignored (AR in the figure), the ventricles
are still paced for every sensed atrial event (AS in the figure),
which results in rapid and irregular pacing of the ventricles
with rates up to 150 beats per minutes, creating a ventricular
tachycardia. At rates this fast, the ventricles do not have enough
time to fill between contractions, and pumping efficiency suffers.

Figure 5. DDD mode: When the VHM is in AFL, the pacemaker induces a
ventricular tachycardia which inhibits pumping. In bradycardia, the pacemaker
can maintain atrio-ventricular synchrony and provides optimal pumping.

do close-loop simulation with pacemaker software for several
clinically-relevant cases and produce template-based ECG signals. The VHM platform builds upon this modeling technique
and allows for cardiac device verification and interaction with
real devices.

Figure 6.
Mode switch: When the VHM is in AFL, the pacemaker can
switch modes (MS) to VDI and slow the ventricular rate, preventing ventricular
tachycardia. When the VHM switches to bradycardia, the pacemaker switches
modes back to DDD and maintains proper rates as well as A-V synchrony.

C.
. AFL with Mode Switch
For patients who require dual chamber pacing due to bradycardia and have intermittent supraventricular tachycardias, a
more advanced mode of pacemaker operation is necessary. The
mode switch operation can disable the atrial pacing function of a
DDD mode pacemaker and turn it into a VDI mode pacemaker
during supraventricular tachycardias while switching back to
DDD mode when the AFL terminates. Fig. 6 illustrates how
a mode-switch would occur in closed-loop operation with the
VHM. The pacemaker starts in DDD mode. The pacemaker
constantly monitors the atrial beat-to-beat interval and records
the number of intervals shorter than 500ms. When there are
five consecutive short intervals in the atrial channel (both AR
and AS), mode-switch occurs from DDD to VDI mode. In VDI
mode, the pacemaker decouples atrial sensing and ventricular
pacing. The ventricles are paced at the LRI of 800ms and only
when a ventricular event has not been sensed.
Most supraventricular tachycardias are transient and eventually terminate on their own. The pacemaker must be able to
mode-switch out of VDI mode to regain its normal operation
when the tachycardia terminates. The pacemaker continues
to monitor the atrial rate in order to detect when the AFL
terminates, characterized by an interval recorded to be longer
than 500ms. This triggers the reverse mode switch from VDI
to DDD. If the interval length exceeds the LRI interval, the
pacemaker will switch to DDD mode and simultaneously deliver
an atrial pace to maintain natural conduction pattern.
V.R ELATED W ORK
Many researchers have previously tackled the problem of
modeling cardiac arrhythmias. [10] and [11] have used a threedimensional discrete element mesh to model supraventricular
tachycardias, while [12] and [13] modeled the activity of
individual ion channels to simulate arrhythmias. These models
were created for research or diagnostic purposes and do not
have the capability to have closed-loop interaction with medical
devices. Medtronic’s Virtual Interactive Patient simulator can be
used in closed-loop operation with real medical devices, but the
sophistication of this signal generator allows it to be used as a
training tool only and not during the testing of device software
itself[14]. [15] also extracted the timing properties of the cardiac
conduction system to model the heart. Their model was able to

VI.D ISCUSSION
As the algorithms used in implantable medical devices become more complex, the design of bug-free medical device
software is becoming an increasingly difficult problem. The
high-level diagnostic and therapeutic operations of artificial
pacemakers requires a dynamic and interactive testing platform
to fully validate their functionality. The VHM provides closedloop interaction with both medical device hardware and software
implementations. We presented a case study to demonstrate how
this closed-loop interaction can be used to show the necessity
and validate the high-level pacemaker mode-switch operation.
The basic pacemaker modes VVI and DDD are successful
in managing individual cardiac arrhythmias. In reality, the
human heart is not restricted to a single arrhythmic state and
consequently requires a variety of therapeutic modalities. In the
future, the VHM will be extended to validate other high-level
operations such as rate hysteresis, rate smoothing, and atrial
flutter response.
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